Factors associated with Quitline and pharmacotherapy utilisation among low-socioeconomic status smokers

Veronica C. Boland, Richard P. Mattick, Mohammad Siahpush, Daniel Barker, Christopher M. Doran, Kristy A. Martire, Billie Bonevski, Hayden McRobbie, Ron Borland, Michael Farrell, Robert West, Ryan J. Courtney

Research output: Contribution to journalArticle

Abstract

Aims: To examine factors associated with Quitline and pharmacotherapy utilisation in low socioeconomic status (low-SES) smokers enrolled in a smoking cessation trial. Methods: Baseline data was used from a large-scale smoking cessation randomised controlled trial (RCT). Logistic regression models were used to examine predictors of treatment utilisation prior to entering the RCT and perceived effectiveness of past and future use. Results: A total of 1047 smokers consented and prior to enrolment 92% had previously tried to quit smoking, 86% had ever used quit support, 83% had used pharmacotherapy at least once and 38% had ever utilised Quitline. For those who had used pharmacotherapies, 71% used NRT, of which 21% had used dual NRT products. In the last 12-months, 27% utilised Quitline and 50% utilised NRT. Ever use of Quitline was negatively associated with self-efficacy to quit (OR: 0.80; 95% CI: 0.68, 0.94 p <.01) and positively associated with being diagnosed with a mental health condition (OR: 1.50; 95% CI: 1.01, 2.25 p <.05). Recent use of NRT was positively associated with mental health condition (OR: 1.39; 95% CI: 1.02, 1.90 p <.05) and negatively associated with alcohol consumption (OR: 0.69; 95% CI: 0.52, 0.92 p <.01). Conclusion: Past use of Quitline and pharmacotherapy treatment was associated with self-efficacy to quit, sociodemographic variables, mental health conditions and alcohol consumption. Community-based strategies that target smoking, mental health and drug and alcohol problems may overcome some of the barriers that prevent low-SES populations from engaging with smoking cessation support.

LanguageEnglish (US)
Pages113-120
Number of pages8
JournalAddictive Behaviors
Volume89
DOIs
StatePublished - Feb 1 2019

Fingerprint

Drug therapy
Social Class
Mental Health
Smoking Cessation
Health
Drug Therapy
Alcohols
Self Efficacy
Alcohol Drinking
Randomized Controlled Trials
Logistic Models
Smoking
Logistics
Therapeutics
Pharmaceutical Preparations
Population

Keywords

  • Randomised controlled trial
  • Smoking cessation
  • Socioeconomic factors
  • Treatment engagement

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Clinical Psychology
  • Toxicology
  • Psychiatry and Mental health

Cite this

Factors associated with Quitline and pharmacotherapy utilisation among low-socioeconomic status smokers. / Boland, Veronica C.; Mattick, Richard P.; Siahpush, Mohammad; Barker, Daniel; Doran, Christopher M.; Martire, Kristy A.; Bonevski, Billie; McRobbie, Hayden; Borland, Ron; Farrell, Michael; West, Robert; Courtney, Ryan J.

In: Addictive Behaviors, Vol. 89, 01.02.2019, p. 113-120.

Research output: Contribution to journalArticle

Boland, VC, Mattick, RP, Siahpush, M, Barker, D, Doran, CM, Martire, KA, Bonevski, B, McRobbie, H, Borland, R, Farrell, M, West, R & Courtney, RJ 2019, 'Factors associated with Quitline and pharmacotherapy utilisation among low-socioeconomic status smokers' Addictive Behaviors, vol. 89, pp. 113-120. https://doi.org/10.1016/j.addbeh.2018.09.029
Boland, Veronica C. ; Mattick, Richard P. ; Siahpush, Mohammad ; Barker, Daniel ; Doran, Christopher M. ; Martire, Kristy A. ; Bonevski, Billie ; McRobbie, Hayden ; Borland, Ron ; Farrell, Michael ; West, Robert ; Courtney, Ryan J. / Factors associated with Quitline and pharmacotherapy utilisation among low-socioeconomic status smokers. In: Addictive Behaviors. 2019 ; Vol. 89. pp. 113-120.
@article{a327ba04b635464385a402888f983a25,
title = "Factors associated with Quitline and pharmacotherapy utilisation among low-socioeconomic status smokers",
abstract = "Aims: To examine factors associated with Quitline and pharmacotherapy utilisation in low socioeconomic status (low-SES) smokers enrolled in a smoking cessation trial. Methods: Baseline data was used from a large-scale smoking cessation randomised controlled trial (RCT). Logistic regression models were used to examine predictors of treatment utilisation prior to entering the RCT and perceived effectiveness of past and future use. Results: A total of 1047 smokers consented and prior to enrolment 92{\%} had previously tried to quit smoking, 86{\%} had ever used quit support, 83{\%} had used pharmacotherapy at least once and 38{\%} had ever utilised Quitline. For those who had used pharmacotherapies, 71{\%} used NRT, of which 21{\%} had used dual NRT products. In the last 12-months, 27{\%} utilised Quitline and 50{\%} utilised NRT. Ever use of Quitline was negatively associated with self-efficacy to quit (OR: 0.80; 95{\%} CI: 0.68, 0.94 p <.01) and positively associated with being diagnosed with a mental health condition (OR: 1.50; 95{\%} CI: 1.01, 2.25 p <.05). Recent use of NRT was positively associated with mental health condition (OR: 1.39; 95{\%} CI: 1.02, 1.90 p <.05) and negatively associated with alcohol consumption (OR: 0.69; 95{\%} CI: 0.52, 0.92 p <.01). Conclusion: Past use of Quitline and pharmacotherapy treatment was associated with self-efficacy to quit, sociodemographic variables, mental health conditions and alcohol consumption. Community-based strategies that target smoking, mental health and drug and alcohol problems may overcome some of the barriers that prevent low-SES populations from engaging with smoking cessation support.",
keywords = "Randomised controlled trial, Smoking cessation, Socioeconomic factors, Treatment engagement",
author = "Boland, {Veronica C.} and Mattick, {Richard P.} and Mohammad Siahpush and Daniel Barker and Doran, {Christopher M.} and Martire, {Kristy A.} and Billie Bonevski and Hayden McRobbie and Ron Borland and Michael Farrell and Robert West and Courtney, {Ryan J.}",
year = "2019",
month = "2",
day = "1",
doi = "10.1016/j.addbeh.2018.09.029",
language = "English (US)",
volume = "89",
pages = "113--120",
journal = "Addictive Behaviors",
issn = "0306-4603",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Factors associated with Quitline and pharmacotherapy utilisation among low-socioeconomic status smokers

AU - Boland, Veronica C.

AU - Mattick, Richard P.

AU - Siahpush, Mohammad

AU - Barker, Daniel

AU - Doran, Christopher M.

AU - Martire, Kristy A.

AU - Bonevski, Billie

AU - McRobbie, Hayden

AU - Borland, Ron

AU - Farrell, Michael

AU - West, Robert

AU - Courtney, Ryan J.

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Aims: To examine factors associated with Quitline and pharmacotherapy utilisation in low socioeconomic status (low-SES) smokers enrolled in a smoking cessation trial. Methods: Baseline data was used from a large-scale smoking cessation randomised controlled trial (RCT). Logistic regression models were used to examine predictors of treatment utilisation prior to entering the RCT and perceived effectiveness of past and future use. Results: A total of 1047 smokers consented and prior to enrolment 92% had previously tried to quit smoking, 86% had ever used quit support, 83% had used pharmacotherapy at least once and 38% had ever utilised Quitline. For those who had used pharmacotherapies, 71% used NRT, of which 21% had used dual NRT products. In the last 12-months, 27% utilised Quitline and 50% utilised NRT. Ever use of Quitline was negatively associated with self-efficacy to quit (OR: 0.80; 95% CI: 0.68, 0.94 p <.01) and positively associated with being diagnosed with a mental health condition (OR: 1.50; 95% CI: 1.01, 2.25 p <.05). Recent use of NRT was positively associated with mental health condition (OR: 1.39; 95% CI: 1.02, 1.90 p <.05) and negatively associated with alcohol consumption (OR: 0.69; 95% CI: 0.52, 0.92 p <.01). Conclusion: Past use of Quitline and pharmacotherapy treatment was associated with self-efficacy to quit, sociodemographic variables, mental health conditions and alcohol consumption. Community-based strategies that target smoking, mental health and drug and alcohol problems may overcome some of the barriers that prevent low-SES populations from engaging with smoking cessation support.

AB - Aims: To examine factors associated with Quitline and pharmacotherapy utilisation in low socioeconomic status (low-SES) smokers enrolled in a smoking cessation trial. Methods: Baseline data was used from a large-scale smoking cessation randomised controlled trial (RCT). Logistic regression models were used to examine predictors of treatment utilisation prior to entering the RCT and perceived effectiveness of past and future use. Results: A total of 1047 smokers consented and prior to enrolment 92% had previously tried to quit smoking, 86% had ever used quit support, 83% had used pharmacotherapy at least once and 38% had ever utilised Quitline. For those who had used pharmacotherapies, 71% used NRT, of which 21% had used dual NRT products. In the last 12-months, 27% utilised Quitline and 50% utilised NRT. Ever use of Quitline was negatively associated with self-efficacy to quit (OR: 0.80; 95% CI: 0.68, 0.94 p <.01) and positively associated with being diagnosed with a mental health condition (OR: 1.50; 95% CI: 1.01, 2.25 p <.05). Recent use of NRT was positively associated with mental health condition (OR: 1.39; 95% CI: 1.02, 1.90 p <.05) and negatively associated with alcohol consumption (OR: 0.69; 95% CI: 0.52, 0.92 p <.01). Conclusion: Past use of Quitline and pharmacotherapy treatment was associated with self-efficacy to quit, sociodemographic variables, mental health conditions and alcohol consumption. Community-based strategies that target smoking, mental health and drug and alcohol problems may overcome some of the barriers that prevent low-SES populations from engaging with smoking cessation support.

KW - Randomised controlled trial

KW - Smoking cessation

KW - Socioeconomic factors

KW - Treatment engagement

UR - http://www.scopus.com/inward/record.url?scp=85054166147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054166147&partnerID=8YFLogxK

U2 - 10.1016/j.addbeh.2018.09.029

DO - 10.1016/j.addbeh.2018.09.029

M3 - Article

VL - 89

SP - 113

EP - 120

JO - Addictive Behaviors

T2 - Addictive Behaviors

JF - Addictive Behaviors

SN - 0306-4603

ER -